Literature DB >> 24074576

Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaques.

Ivelisse Rivera1, Yashira García, Mohitkumar R Gangwani, Richard J Noel, Lucianette Maldonado, Anil Kumar, Vanessa Rivera-Amill.   

Abstract

Viral protein R (Vpr) is an accessory protein of HIV and SIV involved in the pathogenesis of viral infection. In this study, we monitored SIV evolution in the central nervous system and other organs from morphine-dependent and control animals by sequencing vpr in an attempt to understand the relationship between drug abuse, disease progression, and compartmentalization of viral evolution. Animals in the morphine group developed accelerated disease and died within twenty weeks post-infection. A unique mutation, R50G, was identified in the macaques that survived regardless of morphine exposure. Functional studies revealed that the R50G mutation exhibited altered cellular localization and decreased the expression levels of both IL-6 and IL-8. Our results, therefore, suggest that sequence changes within the SIV/17E-Fr vpr occur regardless of drug abuse but correlate with survival, and that they alter disease progression rates by affecting Vpr functions.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain; HIV; IL-6; IL-8; Morphine; PBMC; Proviral; SIV; Viral evolution; Vpr

Mesh:

Substances:

Year:  2013        PMID: 24074576      PMCID: PMC3844929          DOI: 10.1016/j.virol.2013.07.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  54 in total

1.  SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2006-10-24       Impact factor: 3.616

2.  Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.

Authors:  Rakesh Kumar; Suheydi Orsoni; Lisa Norman; Ashish S Verma; Grissell Tirado; Luis D Giavedoni; Silvija Staprans; Gregory M Miller; Shilpa J Buch; Anil Kumar
Journal:  Virology       Date:  2006-07-28       Impact factor: 3.616

3.  Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.

Authors:  Vanessa Rivera-Amill; Richard J Noel; Suheydi Orsini; Griselle Tirado; José M García; Shilpa Buch; Anil Kumar
Journal:  Virology       Date:  2006-09-28       Impact factor: 3.616

4.  Lack of correlation between SIV-Nef evolution and rapid disease progression in morphine-dependent nonhuman primate model of AIDS.

Authors:  Richard J Noel; Alia Toro-Bahamonde; Ziomara Marrero-Otero; Suheydi Orsini; Ashish S Verma; Rakesh Kumar; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

5.  Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV.

Authors:  Richard J Noel; Ziomara Marrero-Otero; Rakesh Kumar; Gladys S Chompre-González; Ashish S Verma; Anil Kumar
Journal:  Virology       Date:  2006-04-27       Impact factor: 3.616

6.  Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort.

Authors:  Leon Cali; Bin Wang; Meriet Mikhail; Michael J Gill; Brenda Beckthold; Marco Salemi; David A Jans; Sabine C Piller; Nitin K Saksena
Journal:  AIDS Res Hum Retroviruses       Date:  2005-08       Impact factor: 2.205

7.  Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain.

Authors:  Huanyu Dou; Justin Morehead; Jennifer Bradley; Santhi Gorantla; Brent Ellison; Jeff Kingsley; Lynette M Smith; Wei Chao; Galina Bentsman; David J Volsky; Howard E Gendelman
Journal:  Glia       Date:  2006-08-01       Impact factor: 7.452

8.  Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2005-11-28       Impact factor: 3.616

9.  Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.

Authors:  G M Aldrovandi; J A Zack
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

10.  Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients.

Authors:  Daniela Mologni; Paola Citterio; Barbara Menzaghi; Barbara Zanone Poma; Chiara Riva; Valentina Broggini; Alessandro Sinicco; Laura Milazzo; Fulvio Adorni; Stefano Rusconi; Massimo Galli; Agostino Riva
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

View more
  3 in total

1.  CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.

Authors:  Maciej Gonek; Virginia D McLane; David L Stevens; Kumiko Lippold; Hamid I Akbarali; Pamela E Knapp; William L Dewey; Kurt F Hauser; Jason J Paris
Journal:  Brain Behav Immun       Date:  2017-11-13       Impact factor: 7.217

2.  An infectious murine model for studying the systemic effects of opioids on early HIV pathogenesis in the gut.

Authors:  Gregory M Sindberg; Umakant Sharma; Santanu Banerjee; Vidhu Anand; Raini Dutta; Chao-Jiang Gu; David J Volsky; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-12-12       Impact factor: 4.147

Review 3.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.